Shaowei Guo

Shaowei Guo

Auto-generated profile, based on publicly available information

Shaowei Guo

The Fourth Department of Oncology, Hebei General Hospital, Shijiazhuang, China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Cancer Control
Verified
Journal Article
Open access
ZLZhiru Li
Zhiru Li
WZWu Zhang
Wu Zhang
SGShaowei Guo
Shaowei Guo
GQGuoyan Qi Guoyan Qi
Guoyan Qi Guoyan Qi
JHJiandi Huang
Jiandi Huang
LQLi Qingxia
Li Qingxia
Background: Abnormalities in mitochondrial structure or function are closely related to the development of malignant tumors. Mitochondrial metabolic reprogramming provides precursor substances and energy for the vital activities of tumor cells, so that cancer cells can rapidly adapt to the unfavorable environment of hypoxia and nutrient deficiency. Mitochondria can enable tumor cells to gain the ability to proliferate, escape immune responses, and develop drug resistance by altering constitutive junctions, oxidative phosphorylation, oxidative stress, and mitochondrial subcellular relocalization. This greatly reduces the rate of effective clinical control of tumors. Purpose: Explore the major role of mitochondria in cancer, as well as targeted mitochondrial therapies and mitochondria-associated markers. Conclusions: This review provides a comprehensive analysis of the various aspects of mitochondrial aberrations and addresses drugs that target mitochondrial therapy, providing a basis for clinical mitochondria-targeted anti-tumor therapy.